Screener
West Pharmaceutical Services WST Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on the most recent quarter.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's net debt / EBITDA?
- West Pharmaceutical Services (WST) reported net debt / EBITDA of -0.1× in Q2 2026.
- How has West Pharmaceutical Services's net debt / EBITDA changed year-over-year?
- West Pharmaceutical Services's net debt / EBITDA increased by 48.9% year-over-year, from -0.3× to -0.1×.
- What is the long-term trend for West Pharmaceutical Services's net debt / EBITDA?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's net debt / EBITDA has grown at a 1.7% compound annual growth rate (CAGR), from -0.6× to -0.6×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about West Pharmaceutical Services's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude